A Nanobody Activation Immunotherapeutic That Selectively Destroys HER2-Positive Breast Cancer Cells

ChemBioChem - Germany
doi 10.1002/cbic.201500591
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy